NCT01913210

Brief Summary

To determine the effect of ginseng on blood pressure control.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2013

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2013

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2013

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

July 29, 2013

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 31, 2013

Completed
2.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2016

Completed
Last Updated

March 3, 2016

Status Verified

March 1, 2016

Enrollment Period

1 month

First QC Date

July 29, 2013

Last Update Submit

March 2, 2016

Conditions

Blood Pressure

Outcome Measures

Primary Outcomes (1)

  • Systolic Blood Pressure

    1 month

Secondary Outcomes (2)

  • Diastolic Blood Pressure

    1 month

  • Mean Arterial Pressure

    1 month

Interventions

GinsengDIETARY_SUPPLEMENT

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Hypertensive Healthy

You may qualify if:

  • clinical trials in humans
  • randomized treatment allocation
  • ≥ 1 month
  • suitable control
  • viable endpoint data

You may not qualify if:

  • non-human studies
  • non-randomized treatment allocation
  • \< 1 month
  • lack of a suitable control
  • no viable endpoint data
  • trials where ginseng is part of a multi-herbal treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Toronto 3D Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre

Toronto, Ontario, M5C 2T2, Canada

Location

MeSH Terms

Interventions

Asian ginseng

Study Officials

  • Vladimir Vuksan, PhD

    Unity Health Toronto

    PRINCIPAL INVESTIGATOR

  • John Sievenpiper, MD, PhD

    Unity Health Toronto

    PRINCIPAL INVESTIGATOR

  • Allison Komishon, MSc(c)

    Unity Health Toronto

    STUDY DIRECTOR

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 29, 2013

First Posted

July 31, 2013

Study Start

April 1, 2013

Primary Completion

May 1, 2013

Study Completion

January 1, 2016

Last Updated

March 3, 2016

Record last verified: 2016-03

Locations

CA(1)